Sexual and gender minorities (SGM) include persons identifying as lesbian, gay, bisexual, transgender/non-binary, and queer experience a greater cancer burden than their heterosexual or cisgender counterparts. Access to cancer care includes prevention and early detection, however despite known increased risk for various malignancies among SGM individuals, cancer screening rates remain low. This commentary outlines disparities in cancer screening for SGM individuals and provides the current evidence-based screening guidelines for these patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.currproblcancer.2022.100858 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!